◼ Archived
Business
🔮 fades ✓
Personalized mRNA cancer vaccines offer new hope. We explain
Personalized mRNA cancer vaccines spark a biotech gold rush, drawing investors and reshaping oncology treatment.
Merck
18 independently detected trends connected to this subject, with the latest coverage first.
What Archynetys tracks about Merck
This hub groups 18 separate news trends connected to Merck, spanning June 30, 2026 through September 7, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 170 article observations and 154 source signals, led by Business, Health coverage. Use it to compare how individual events emerged, spread and changed over time.
◼ Archived
Business
🔮 fades ✓
Summit Packs A Punch For Merck's Keytruda
6 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Business
How a Big Bet on Cancer Vaccines Brought Moderna Back from the Brink
Moderna's cancer vaccine trials could transform treatment, but the math is still out.
◼ Archived
Business
🔮 fades ✓
Moderna, Merck breakthrough could usher in wave of cancer vaccines
A cancer vaccine breakthrough is stirring debate over profits and public health, as Moderna and Merck's stock prices surge.
◼ Archived
Health
🔮 fades ✓
Congo to receive 70,000 doses of Ervebo Ebola vaccine which has been effective in past outbreaks
The Democratic Republic of the Congo is receiving a large shipment of Ebola vaccines, but the strain of the virus is unknown.
◼ Archived
Business
🔮 fades ✓
Why Is Moderna Stock Down Today?
Moderna's stock is down despite promising news about a cancer vaccine.
◼ Archived
Business
🔮 fades ✓
After Moderna stock surge of 177% on cancer drug breakthrough, here's what Wall Street thinks happens next
Moderna's stock surge on a cancer drug breakthrough has Wall Street abuzz with speculation about the future of cancer treatment.
◼ Archived
Business
Wall St recovers as yields ease; Moderna lifts healthcare stocks
Investors see broad gains across stocks, bonds, gold, and bitcoin as a new Treasury buyback plan shifts market sentiment.
◼ Archived
Business
🔮 fades ✓
Moderna Shares Double on Success of mRNA Cancer Vaccine
Moderna's shares have doubled since August 19th, 2026, as investors react to a breakthrough in cancer treatment.
◼ Archived
Business
🔮 fades ✓
Merck and Moderna say cancer vaccine shows promise in preventing recurrence of melanoma
Shares of Moderna have doubled after its cancer vaccine trial with Merck met key endpoints.
◼ Archived
Business
Moderna surges as Merck-partnered melanoma vaccine cuts recurrence in large trial
Moderna's stock surges as a melanoma vaccine developed with Merck shows promise in a large trial
◼ Archived
Business
🔮 fades ✓
Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial
Moderna's stock surged 160% after the company and Merck announced success in a late-stage melanoma vaccine trial
◼ Archived
Health
Drugmakers uninterested in Trump’s order to split up MMR vaccine
Drugmakers are resisting a Trump-era order to split the MMR vaccine, despite the potential for increased revenue.
◼ Archived
Business
🔮 fades ✓
Merck & Co., Inc., Rahway, N.J., USA Announces Second-Quarter 2026 Financial Results; Highlights Key Regulatory and Clinical Milestones Across Broad, Diverse Pipeline
Merck's mixed financial outlook for 2026 is drawing attention as acquisition costs and new drug sales create opposing trends.
◼ Archived
Business
🔮 fades ✓
With Hopes High for New H.I.V. Prevention Pill, Merck Takes Steps to Ensure Access
Merck is taking steps to ensure global access to its experimental monthly HIV prevention pill.
◼ Archived
Business
🔮 fades ✓
Kalshi Will Offer Sports-Style Betting on Drug Trial Results
Prediction platform Kalshi is launching sports-style betting markets focused on biotech clinical trials and FDA drug approvals.
◼ Archived
Business
🔮 holds ✓
The F.D.A. Approves a New Pill to Slash Cholesterol Levels
The FDA has approved a first-of-its-kind cholesterol pill from Merck designed to drive cholesterol levels lower than statins.
◼ Archived
Business
🔮 fades ✓
EXCLUSIVE: US House committee opens investigation into Merck, AbbVie China drug trials
A US House committee has launched an investigation into Merck and AbbVie regarding drug trials conducted in China.